Clinical efficiency of quadrivalent HPV (types 6/11/16/18) vaccine in patients with recurrent respiratory papillomatosis.
Phase of Trial: Phase II
Latest Information Update: 16 Dec 2015
At a glance
- Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
- Indications Recurrent respiratory papillomatosis
- Focus Therapeutic Use
- 16 Dec 2015 New trial record